Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)
A Randomized, Multicenter, Open-Label, Non-Inferiority, Phase III Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia
Sponsor: Acerta Pharma BV
Listed as NCT02477696, this PHASE3 trial focuses on Chronic Lymphocytic Leukemia and remains ongoing. Sponsored by Acerta Pharma BV, it has been updated 28 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
28 versions recorded-
Dec 2025 — Present [monthly]
Active Not Recruiting PHASE3
-
Oct 2025 — Dec 2025 [monthly]
Active Not Recruiting PHASE3
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE3
-
Jul 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE3
-
Mar 2025 — Jul 2025 [monthly]
Active Not Recruiting PHASE3
▶ Show 23 earlier versions
-
Dec 2024 — Mar 2025 [monthly]
Active Not Recruiting PHASE3
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
Mar 2024 — Jun 2024 [monthly]
Active Not Recruiting PHASE3
-
Jan 2024 — Mar 2024 [monthly]
Active Not Recruiting PHASE3
-
Aug 2023 — Jan 2024 [monthly]
Active Not Recruiting PHASE3
-
Apr 2023 — Aug 2023 [monthly]
Active Not Recruiting PHASE3
-
Jan 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE3
-
Sep 2022 — Jan 2023 [monthly]
Active Not Recruiting PHASE3
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE3
-
Feb 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE3
-
Sep 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE3
-
Jun 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE3
-
Mar 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE3
-
Jan 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
May 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting PHASE3
-
Jan 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2017 — Jan 2018 [monthly]
Recruiting PHASE3
-
Feb 2017 — Jun 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Acerta Pharma BV
For direct contact, visit the study record on ClinicalTrials.gov .